Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
This study is currently recruiting participants.
Verified by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), September 2008
Sponsors and Collaborators: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
ClinicalTrials.gov Identifier: NCT00082108
  Purpose

Myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) are inherited disorders characterized by progressive muscle weakness and loss of muscle tissue. The purpose of this registry is to connect people with DM or FSHD with researchers studying these diseases. The registry will offer individuals with DM and FSHD an opportunity to participate in research that focuses of their diseases. The registry will also help scientists to accomplish research on DM and FSHD and to distribute their findings to patients and care providers.


Condition
Myotonic Dystrophy
Muscular Dystrophy, Facioscapulohumeral
Muscular Dystrophy

Genetics Home Reference related topics: familial encephalopathy with neuroserpin inclusion bodies myotonic dystrophy potassium-aggravated myotonia
MedlinePlus related topics: Muscular Dystrophy
U.S. FDA Resources
Study Type: Observational
Study Design: Prospective
Official Title: National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members

Further study details as provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS):

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 2300
Study Start Date: September 2000
Estimated Study Completion Date: September 2010
Detailed Description:

The National Registry of DM and FSHD Patients and Family Members was developed to create a link between patients and scientists in order to promote research on these rare illnesses. The Registry is sponsored by the National Institutes of Health.

Patients that are interested in joining the Registry can email or call to request an application or download the forms from the website (www.dystrophyregistry.org). The Application packet contains:

  • A Patient Information Form, which asks about your muscle strength, general health, and how your disease affects your daily life
  • A Medical Records Release Form, which allows us to contact your doctor and obtain records about your diagnosis
  • An informed Consent Form, which describes the study's purpose and what you can expect while you are involved with the project.

After you are enrolled in the Registry, there are several ways to participate in research. The activities include:

  • Complete an annual update form to help us keep track of how your symptoms change over time.
  • Receive a newsletter once a year about the progress of the Registry, research highlights, and other news related to muscular dystrophy.
  • Receive a letter from the Registry when researchers are looking for patients to take part in studies. These projects may include filling out questionnaires, exploring new treatments and other types of research.

There is no obligation to participate in these activities. Taking part in any study or filling out the annual updates are completely up to you.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Participants will volunteer to participate in this study. The study will be advertised through neuromuscular disease clinics, the National Registry website, Patient Advocacy Groups and MDA Clinics through out the United States.

Criteria

Inclusion Criteria:

  • Diagnosed with DM, FSHD, or related diseases or are an unaffected family member of someone diagnosed with one of these diseases
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00082108

Contacts
Contact: Registry Coordinator 888-925-4302 dystrophy_registry@urmc.rochester.edu

Locations
United States, New York
University of Rochester Medical Center, Department of Neurology Recruiting
Rochester, New York, United States, 14642
Contact: Registry Coordinator     888-925-4302     dystrophy_registry@urmc.rochester.edu    
Principal Investigator: Richard T. Moxley, III, MD            
Sub-Investigator: Rabi Tawil, MD            
Sponsors and Collaborators
Investigators
Principal Investigator: Richard T. Moxley, III, MD University of Rochester Medical Center, Department of Neurology
  More Information

Click here for more information about the National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members  This link exits the ClinicalTrials.gov site

Responsible Party: University of Rochester ( Dr. Richard T. Moxley, III, MD )
Study ID Numbers: NIAMS-104, NO1-AR-0-2250
Study First Received: April 29, 2004
Last Updated: September 3, 2008
ClinicalTrials.gov Identifier: NCT00082108  
Health Authority: United States: Federal Government

Keywords provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS):
Registry
FSHD
Muscular Dystrophy
Facioscapulohumeral Myotonic Dystrophy

Study placed in the following topic categories:
Dystrophia myotonica 1
Myotonic Disorders
Neurodegenerative Diseases
Muscular Dystrophy, Facioscapulohumeral
Myotonia atrophica
Muscular Dystrophies
Muscular Diseases
Heredodegenerative Disorders, Nervous System
Muscular Disorders, Atrophic
Musculoskeletal Diseases
Neuromuscular Diseases
Genetic Diseases, Inborn
Myotonic Dystrophy
Facioscapulohumeral muscular dystrophy 1a
Atrophy
Muscular dystrophy
Landouzy-Dejerine muscular dystrophy

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on January 15, 2009